Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 06, 2026 14:32 ET | Source: Robbins LLP

ADLX Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Aldeyra Therapeutics, Inc. Class Action Lawsuit

Robbins LLP is Investigating Allegations that Aldeyra Therapeutics, Inc. (ALDX) Misled Investors Regarding its Lead Drug Candidate
August 17, 2023 15:59 ET | Source: Robbins LLP

ALDX Investor Alert: Robbins LLP Urges Investors to Contact the Firm for Information about the Upcoming Lead Plaintiff Deadline in Aldeyra Therapeutics, Inc. Class Action Lawsuit

SAN DIEGO, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of investors who purchased or otherwise acquired Aldeyra (NASDAQ: ALDX)...
August 11, 2023 15:11 ET | Source: Robbins LLP

ALDX Stock News: Shareholders with Significant Losses in Aldeyra Therapeutics, Inc. Should Contact Robbins LLP

SAN DIEGO, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of investors who purchased or otherwise acquired Aldeyra (NASDAQ: ALDX)...
August 04, 2023 18:25 ET | Source: Robbins LLP

Aldeyra Therapeutics, Inc. (ALDX) Shareholder Notice: Robbins LLP Reminds Shareholders of Class Action Filed Against Aldeyra Therapeutics, Inc.

SAN DIEGO, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of investors who purchased or otherwise acquired Aldeyra (NASDAQ: ALDX)...